Analysis for Siemens Energy
Analysis summary
Siemens Energy (ENR.DE) currently has a total score of 82 points, placing it in the very strong range. The score is made up of Performance (98), Stability (45) and Trend (97). The profile is clearly uneven: Performance stands out while Stability is more neutral.
Performance scores 98 points (very strong). Key strength: 3Y return at 755.1 %. Even the weakest return is still strong in absolute terms: 5Y return at 416.4 %.
Stability scores 45 points (neutral). Key strength: return/volatility ratio at 3.17. Weaker metric: max drawdown (3Y) at -79.6 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 97 points (very strong). Key strength: Price is about 34.3 % above SMA100. Even the weakest metric remains solid in absolute terms: trend strength at 0.94.
Overall, the very strong total score is driven mainly by Performance and Trend; Stability is the biggest lever for improvement. On a metric level, 3Y return stands out, while max drawdown (3Y) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Siemens Energy fit best in FoxScore?
- Siemens Energy fits a more opportunity-seeking investor type in FoxScore: performance is the strongest sub-score. That suggests above-average historical returns — but check stability to ensure the performance wasn’t “paid for” with high volatility or deep drawdowns.
- How meaningful is the available history for Siemens Energy?
- Siemens Energy currently has about 5.4 years of price history since it started trading. This lets you judge how it behaved in its market phases since launch, but long-term conclusions across multiple cycles are naturally limited.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.